CHEK2 and adenocarcinoma: The hepatocellular carcinoma cell line, HepG2, had a lower IC50 compared to the adenocarcinoma cell line, A549, while the changes in phosphorylation and quantity of both Chk2 and FANCDC2 were more pronounced in the A549 cells.